• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

致病性 T 细胞通过增强 Tregs 对小鼠自身免疫性糖尿病具有矛盾的保护作用。

Pathogenic T cells have a paradoxical protective effect in murine autoimmune diabetes by boosting Tregs.

机构信息

1Université Pierre et Marie Curie -- Univ Paris 06, France.

出版信息

J Clin Invest. 2010 Dec;120(12):4558-68. doi: 10.1172/JCI42945. Epub 2010 Nov 22.

DOI:10.1172/JCI42945
PMID:21099113
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2993590/
Abstract

CD4+CD25+Foxp3+ Tregs play a major role in prevention of autoimmune diseases. The suppressive effect of Tregs on effector T cells (Teffs), the cells that can mediate autoimmunity, has been extensively studied. However, the in vivo impact of Teff activation on Tregs during autoimmunity has not been explored. In this study, we have shown that CD4+ Teff activation strongly boosts the expansion and suppressive activity of Tregs. This helper function of CD4+ T cells, which we believe to be novel, was observed in the pancreas and draining lymph nodes in mouse recipients of islet-specific Teffs and Tregs. Its physiological impact was assessed in autoimmune diabetes. When islet-specific Teffs were transferred alone, they induced diabetes. Paradoxically, when the same Teffs were cotransferred with islet-specific Tregs, they induced disease protection by boosting Treg expansion and suppressive function. RNA microarray analyses suggested that TNF family members were involved in the Teff-mediated Treg boost. In vivo experiments showed that this Treg boost was partially dependent on TNF but not on IL-2. This feedback regulatory loop between Teffs and Tregs may be critical to preventing or limiting the development of autoimmune diseases.

摘要

CD4+CD25+Foxp3+Tregs 在预防自身免疫性疾病中发挥重要作用。Tregs 对效应 T 细胞(Teffs)的抑制作用,即能够介导自身免疫的细胞,已得到广泛研究。然而,Teff 活化在自身免疫过程中对 Tregs 的体内影响尚未得到探索。在本研究中,我们表明 CD4+Teff 活化强烈促进了 Tregs 的扩增和抑制活性。我们认为这种 CD4+T 细胞的辅助功能是新颖的,在胰岛特异性 Teffs 和 Tregs 小鼠受体内的胰腺和引流淋巴结中观察到了这种功能。在自身免疫性糖尿病中评估了其生理影响。当单独转导胰岛特异性 Teffs 时,它们会引发糖尿病。矛盾的是,当相同的 Teffs 与胰岛特异性 Tregs 共转导时,它们通过促进 Treg 扩增和抑制功能诱导疾病保护。RNA 微阵列分析表明 TNF 家族成员参与了 Teff 介导的 Treg 扩增。体内实验表明,这种 Treg 扩增部分依赖于 TNF,但不依赖于 IL-2。Teffs 和 Tregs 之间的这种反馈调节环可能对预防或限制自身免疫性疾病的发展至关重要。

相似文献

1
Pathogenic T cells have a paradoxical protective effect in murine autoimmune diabetes by boosting Tregs.致病性 T 细胞通过增强 Tregs 对小鼠自身免疫性糖尿病具有矛盾的保护作用。
J Clin Invest. 2010 Dec;120(12):4558-68. doi: 10.1172/JCI42945. Epub 2010 Nov 22.
2
Cyclophosphamide-induced type-1 diabetes in the NOD mouse is associated with a reduction of CD4+CD25+Foxp3+ regulatory T cells.环磷酰胺诱导非肥胖糖尿病(NOD)小鼠发生1型糖尿病与CD4+CD25+Foxp3+调节性T细胞数量减少有关。
J Immunol. 2006 Nov 15;177(10):6603-12. doi: 10.4049/jimmunol.177.10.6603.
3
Interaction of TNF with TNF receptor type 2 promotes expansion and function of mouse CD4+CD25+ T regulatory cells.肿瘤坏死因子(TNF)与2型肿瘤坏死因子受体(TNF receptor type 2)的相互作用可促进小鼠CD4+CD25+调节性T细胞的扩增及功能。
J Immunol. 2007 Jul 1;179(1):154-61. doi: 10.4049/jimmunol.179.1.154.
4
Regulatory T cells prevent transfer of type 1 diabetes in NOD mice only when their antigen is present in vivo.调节性T细胞仅在其抗原存在于体内时才能阻止1型糖尿病在非肥胖糖尿病(NOD)小鼠中的转移。
J Immunol. 2008 Oct 1;181(7):4516-22. doi: 10.4049/jimmunol.181.7.4516.
5
Diabetes in non-obese diabetic mice is not associated with quantitative changes in CD4+ CD25+ Foxp3+ regulatory T cells.非肥胖糖尿病小鼠中的糖尿病与CD4+ CD25+ Foxp3+调节性T细胞的数量变化无关。
Immunology. 2007 May;121(1):15-28. doi: 10.1111/j.1365-2567.2007.02546.x.
6
Reduced IL-2 expression in NOD mice leads to a temporal increase in CD62Llo FoxP3+ CD4+ T cells with limited suppressor activity.在 NOD 小鼠中降低 IL-2 的表达会导致 CD62LloFoxP3+CD4+T 细胞的暂时增加,但其抑制活性有限。
Eur J Immunol. 2011 May;41(5):1480-1490. doi: 10.1002/eji.201040890. Epub 2011 Apr 20.
7
Low TCR signal strength induces combined expansion of Th2 and regulatory T cell populations that protect mice from the development of type 1 diabetes.低TCR信号强度诱导Th2细胞和调节性T细胞群体联合扩增,从而保护小鼠免于患1型糖尿病。
Diabetologia. 2014 Jul;57(7):1428-36. doi: 10.1007/s00125-014-3233-9. Epub 2014 Apr 16.
8
Can TNF-α boost regulatory T cells?TNF-α 可以促进调节性 T 细胞吗?
J Clin Invest. 2010 Dec;120(12):4190-2. doi: 10.1172/JCI45262. Epub 2010 Nov 22.
9
B7-2 (CD86) controls the priming of autoreactive CD4 T cell response against pancreatic islets.B7-2(CD86)控制针对胰岛的自身反应性CD4 T细胞反应的启动。
J Immunol. 2004 Sep 15;173(6):3631-9. doi: 10.4049/jimmunol.173.6.3631.
10
β-cell-specific IL-2 therapy increases islet Foxp3+Treg and suppresses type 1 diabetes in NOD mice.β 细胞特异性白细胞介素-2 治疗可增加胰岛 Foxp3+Treg 并抑制 NOD 小鼠的 1 型糖尿病。
Diabetes. 2013 Nov;62(11):3775-84. doi: 10.2337/db13-0669. Epub 2013 Jul 24.

引用本文的文献

1
Targeting cytokine and chemokine signaling pathways for cancer therapy.针对细胞因子和趋化因子信号通路的癌症治疗。
Signal Transduct Target Ther. 2024 Jul 22;9(1):176. doi: 10.1038/s41392-024-01868-3.
2
Tregs from human blood differentiate into nonlymphoid tissue-resident effector cells upon TNFR2 costimulation.Tregs(调节性 T 细胞)在 TNFR2(肿瘤坏死因子受体 2)共刺激下从人血液中分化为非淋巴组织驻留效应细胞。
JCI Insight. 2024 Mar 8;9(5):e172942. doi: 10.1172/jci.insight.172942.
3
Teplizumab in Type 1 Diabetes Mellitus: An Updated Review.替普珠单抗治疗 1 型糖尿病:最新综述。
touchREV Endocrinol. 2023 Nov;19(2):22-30. doi: 10.17925/EE.2023.19.2.7. Epub 2023 Oct 6.
4
Pancreatic draining lymph nodes (PLNs) serve as a pathogenic hub contributing to the development of type 1 diabetes.胰腺引流淋巴结(PLNs)作为一个致病中心,促进1型糖尿病的发展。
Cell Biosci. 2023 Aug 28;13(1):156. doi: 10.1186/s13578-023-01110-7.
5
Functional interrogation of lymphocyte subsets in alopecia areata using single-cell RNA sequencing.单细胞 RNA 测序技术在斑秃中对淋巴细胞亚群的功能研究。
Proc Natl Acad Sci U S A. 2023 Jul 18;120(29):e2305764120. doi: 10.1073/pnas.2305764120. Epub 2023 Jul 10.
6
The dichotomous outcomes of TNFα signaling in CD4 T cells.TNFα 信号在 CD4 T 细胞中的双重结局。
Front Immunol. 2022 Nov 16;13:1042622. doi: 10.3389/fimmu.2022.1042622. eCollection 2022.
7
2D and 3D cultured human umbilical cord-derived mesenchymal stem cell-conditioned medium has a dual effect in type 1 diabetes model in rats: immunomodulation and beta-cell regeneration.二维和三维培养的人脐带间充质干细胞条件培养基在大鼠1型糖尿病模型中具有双重作用:免疫调节和β细胞再生。
Inflamm Regen. 2022 Nov 30;42(1):55. doi: 10.1186/s41232-022-00241-7.
8
TNFR2 antagonist and agonist: a potential therapeutics in cancer immunotherapy.肿瘤坏死因子受体 2 拮抗剂和激动剂:癌症免疫治疗的潜在治疗方法。
Med Oncol. 2022 Sep 29;39(12):215. doi: 10.1007/s12032-022-01772-2.
9
The Mechanisms of Effector Th Cell Responses Contribute to Treg Cell Function: New Insights into Pathogenesis and Therapy of Asthma.效应性 T 细胞应答的机制有助于 Treg 细胞的功能:哮喘发病机制和治疗的新见解。
Front Immunol. 2022 Jul 11;13:862866. doi: 10.3389/fimmu.2022.862866. eCollection 2022.
10
TNFR2 Costimulation Differentially Impacts Regulatory and Conventional CD4 T-Cell Metabolism.TNFR2 共刺激作用对调节性和常规 CD4 T 细胞代谢的影响不同。
Front Immunol. 2022 Jun 30;13:881166. doi: 10.3389/fimmu.2022.881166. eCollection 2022.

本文引用的文献

1
IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells.IL-2 通过对胰腺调节性 T 细胞的局部作用逆转 NOD 小鼠的 1 型糖尿病。
J Exp Med. 2010 Aug 30;207(9):1871-8. doi: 10.1084/jem.20100209. Epub 2010 Aug 2.
2
Membrane tumor necrosis factor (TNF) induces p100 processing via TNF receptor-2 (TNFR2).膜型肿瘤坏死因子 (TNF) 通过 TNF 受体-2 (TNFR2) 诱导 p100 加工。
J Biol Chem. 2010 Mar 5;285(10):7394-404. doi: 10.1074/jbc.M109.037341. Epub 2009 Dec 28.
3
Regulatory T cells exert checks and balances on self tolerance and autoimmunity.调节性 T 细胞对自身耐受和自身免疫起着制衡作用。
Nat Immunol. 2010 Jan;11(1):7-13. doi: 10.1038/ni.1818. Epub 2009 Dec 17.
4
Feedback control of regulatory T cell homeostasis by dendritic cells in vivo.树突状细胞在体内对调节性T细胞稳态的反馈控制
J Exp Med. 2009 Aug 31;206(9):1853-62. doi: 10.1084/jem.20090746. Epub 2009 Aug 10.
5
Negative feedback control of the autoimmune response through antigen-induced differentiation of IL-10-secreting Th1 cells.通过抗原诱导分泌白细胞介素-10的Th1细胞分化对自身免疫反应进行负反馈控制。
J Exp Med. 2009 Aug 3;206(8):1755-67. doi: 10.1084/jem.20082118. Epub 2009 Jul 27.
6
The initial phase of an immune response functions to activate regulatory T cells.免疫反应的初始阶段起着激活调节性T细胞的作用。
J Immunol. 2009 Jul 1;183(1):332-9. doi: 10.4049/jimmunol.0900691.
7
Foxp3+ regulatory T cells: differentiation, specification, subphenotypes.Foxp3+调节性T细胞:分化、特性、亚表型
Nat Immunol. 2009 Jul;10(7):689-95. doi: 10.1038/ni.1760.
8
Mechanisms of foxp3+ T regulatory cell-mediated suppression.Foxp3+调节性T细胞介导的抑制机制。
Immunity. 2009 May;30(5):636-45. doi: 10.1016/j.immuni.2009.04.010.
9
The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation.转录因子T-bet在1型炎症期间控制调节性T细胞的稳态和功能。
Nat Immunol. 2009 Jun;10(6):595-602. doi: 10.1038/ni.1731. Epub 2009 May 3.
10
Regulatory T cells in the control of host-microorganism interactions (*).调节性T细胞在宿主-微生物相互作用的调控中(*)。
Annu Rev Immunol. 2009;27:551-89. doi: 10.1146/annurev.immunol.021908.132723.